Evaluates nanoparticle vaccines for dengue virus infection, indicating potential for improved immunity.
Dengue virus (DENV) is one of the most prevalent mosquito-borne pathogens, with almost half of the global population at risk of infection. While most cases are mild, severe illness and...
No takes yet. Share an insight, caveat, or question.
Murphy et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: